Síndrome antifosfolípido: espectro clínico, inmunológico y tratamiento
El Síndrome antifosfolípido (SAF) se caracteriza por ser un estado de hipercoagulabilidad manifestado por trombosis venosas y/o arteriales, aumento de morbimortalidad materno- fetal y alteraciones hematológicas mediadas por anticuerpos. De estos, los más
María Teresa Romero de Albrecht
doaj
Immunoglobulin A Antiphospholipid Antibodies in Patients With Chilblain-like Lesions During the COVID-19 Pandemic. [PDF]
Cuenca Saez MA, Gomez-Biezna SL.
europepmc +1 more source
[Assessment of antiphospholipid antibodies during the follow-up of patients after SARS-CoV-2 infection]. [PDF]
Rosales-Castillo A, Sabio JM.
europepmc +1 more source
Anti-phospholipid Sindrome. A case report
A case of a young female patient suffering from an anti-phospholipid syndrome whose evolution was accompanied by repeated episodes of jaundice and, who finally deceased due to a cerebrovascular ischemia is presented.
José M. Carles Zerquera +2 more
doaj +2 more sources
[Skin lesions in children during the first wave of the SARS-CoV-2 pandemic]. [PDF]
Carazo Gallego B +5 more
europepmc +1 more source
Uterine necrosis following hemostatic compression suture: case report and review of the literature [PDF]
García-Guerra R +4 more
europepmc +1 more source
[Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine]. [PDF]
Tejada Cifuentes F +17 more
europepmc +1 more source
43° Congreso Nacional de la Sociedad Española de Medicina Interna (SEMI): Gijón, 23-25 de Noviembre de 2022. [PDF]
europepmc +1 more source
[Renal infaction in a patient with COVID-19]. [PDF]
Cuevas Tascón G +10 more
europepmc +1 more source

